
Platelet-Rich Plasma vs. Autologous Blood Injection for Plantar Fasciitis

Platelet-Rich Plasma vs. Autologous Blood Injection for Plantar Fasciitis
Platelet-Rich Plasma vs Autologous Blood Injection to Treat Plantar Fasciitis: A Prospective Randomized, Double-Blinded, Controlled Trial
Foot Ankle Int . 2022 Sep;43(9):1211-1218.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Sixty patients with plantar fasciitis were randomized to receive an ultrasound-guided injection of platelet-rich plasma (n=30) or autologous blood product. The outcomes of interest included pain on a Visual Analog Scale (VAS) and the Foot and Ankle Disability Index (FADI), measured at 1, 3 and 6 months. Results revealed no significant differences between the two groups in all outcomes, at all time...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!

Join the Conversation
Please Login or Join to leave comments.